PF
SONM icon

Phoenix Financial’s DNA X Inc SONM Stock Holding History

Phoenix Financial’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,427
Closed -$1.86M – 467
2020
Q4 		$1.86M Hold
1,427
– – 0.05% 189
2020
Q3 		$1.88M Sell
1,427
-556
-28% -$894K 0.08% 161
2020
Q2 		$2.71M Buy
+1,983
New +$3.17M 0.12% 132

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.46B AUM 78.13% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $278M AUM 50.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Phoenix Financial's SONM Position: Q1 2021 in Review

Phoenix Financial sold out of DNA X Inc (SONM) in Q1 2021, closing a stake of 1,427 shares — an estimated $1.86M sold.

Phoenix Financial first reported a position in SONM in Q2 2020 and held it in 3 quarters. The position peaked at $2.71M in Q2 2020. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

  • Phoenix Financial reported no remaining DNA X Inc position as of Q1 2021 after selling out during the quarter.
  • Phoenix Financial sold 1,427 DNA X Inc shares in Q1 2021, an estimated $1.86M.
  • Phoenix Financial first reported a position in DNA X Inc in Q2 2020 and held it in 3 quarters.
  • Phoenix Financial's DNA X Inc position peaked at $2.71M in Q2 2020.
  • 23 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2021.

Based on Phoenix Financial's 13F filing for Q1 2021, filed 10 May 2021.